Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Ischemic Heart Disease

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 388 articles: HTML format

Single Articles

December 2025
1. KRAMER CM
   The Cardiovascular Imager of the Future.
   J Am Coll Cardiol. 2025 Dec 17:S0735-1097(25)10276.
   PubMed    
   
   
   
2. KANG YM, Giugliano RP, Keech AC, Lopez JAG, et al
   Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER.
   J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)10005.
   PubMed     Abstract available
   
   
   
3. GANATRA S, Barac A, Armenian S, Cambareri C, et al
   Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American Col
   J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)09916.
   PubMed    
   
   
   
4. DANILOV A, Duran-Luciano P, Yuan Y, De Oliveira Gomes D, et al
   Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos.
   J Am Coll Cardiol. 2025;86:2292-2310.
   PubMed     Abstract available
   
   
   
5. HAKEEM A, Shah JA, Kumar R, Ali A, et al
   Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.
   J Am Coll Cardiol. 2025;86:2330-2345.
   PubMed     Abstract available
   
   
   
6. KOHSAKA S, Kumamaru H, Sawano M, Mori M, et al
   Nationwide Trends in Coronary Revascularization in Japan, 2017 to 2023: From Decline to Plateau.
   J Am Coll Cardiol. 2025;86:2391-2394.
   PubMed    
   
   
   
7. MORAN AE, Apeagyei AE, Shyong C, Elliott H, et al
   Global Development Assistance for Health Allocated to Cardiovascular Disease Control, 2015 to 2022.
   J Am Coll Cardiol. 2025;86:2388-2390.
   PubMed    
   
   
   
8. WILLIAMS KA SR, Aggarwal M, Agustina R, Dastmalchi LN, et al
   Nutrition and Front-of-Package Food Labeling as a Catalyst for Cardiovascular Health: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee.
   J Am Coll Cardiol. 2025 Dec 5:S0735-1097(25)10156.
   PubMed    
   
   
   
9. DAMLUJI AA, Nanna MG, Menon V
   Frailty in Cardiovascular Disease: Time for a Universal Definition!
   J Am Coll Cardiol. 2025 Dec 3:S0735-1097(25)10032.
   PubMed    
   
   
   
10. LONGENECKER CT
    Embracing Uncertainty: The Future of Cardiovascular Surveillance.
    J Am Coll Cardiol. 2025;86:2158-2160.
    PubMed    
    
    
    
11. SPATZ ES
    Confronting the Global Rise of Obesity and Cardiovascular Disease: The Role of GLP-1 RAs.
    J Am Coll Cardiol. 2025;86:2155-2157.
    PubMed    
    
    
    
12. YAN LL, Nguyen QN, Chen X, Bloomfield GS, et al
    Improving Global Cardiovascular Health by Integrating Primary and Community-Based Care.
    J Am Coll Cardiol. 2025;86:2151-2154.
    PubMed    
    
    
    
13. KHERA R
    Toward a Global Cardiovascular Mission Control: Reimagining Surveillance Through Artificial Intelligence and Digital Health.
    J Am Coll Cardiol. 2025;86:2148-2150.
    PubMed    
    
    
    
14. WITTENBERG RE, Onuma OK
    Adapting Cardiovascular Disease Data to Inform Policy Goals: Global to Local.
    J Am Coll Cardiol. 2025;86:2142-2144.
    PubMed    
    
    
    
15. BIKDELI B, Rashedi S, Pfeferman MB, Barco S, et al
    Venous Thromboembolism: Global Burden of Disease Estimates Are Missing a Common Cardiovascular Condition.
    J Am Coll Cardiol. 2025;86:2135-2138.
    PubMed    
    
    
    
16. SUD M, Marelli AJ, Schull MJ, Ko DT, et al
    Canadian Cardiovascular Care at a Crossroad: Universal But Unequal.
    J Am Coll Cardiol. 2025;86:2124-2126.
    PubMed    
    
    
    
17. AL-KINDI S, Dakhil Z, Alasnag M, Al Suwaidi J, et al
    Cardiovascular Disease in the Middle East and North Africa.
    J Am Coll Cardiol. 2025;86:2115-2117.
    PubMed    
    
    
    
18. THIRUVENGADAM R, Karthikeyan G
    Interpreting Cardiovascular Disease Burden for Low-Middle Income Countries: A Perspective From India.
    J Am Coll Cardiol. 2025;86:2112-2114.
    PubMed    
    
    
    
19. NAEEM U, Sheikh S, Khan UI, Hanif B, et al
    Pakistan's Growing Heartache: Finding Hope for Cardiovascular Health Amid Uncertainty.
    J Am Coll Cardiol. 2025;86:2109-2111.
    PubMed    
    
    
    
20. OKAMURA T, Hirata A
    Current Status of Cardiovascular Disease in Japan: Prevention Strategies, Future Challenges, and Fundamental Lessons.
    J Am Coll Cardiol. 2025;86:2106-2108.
    PubMed    
    
    
    
21. KRUMHOLZ HM
    The Global Burden of Cardiovascular Disease: Not Just a Mirror, But a Compass.
    J Am Coll Cardiol. 2025;86:2103-2105.
    PubMed    
    
    
    November 2025
22. YUAN H, Zhong W, Xu S, Zhong H, et al
    Data-Driven Insights Into LDL-C and Cardiovascular Mortality in China: Implications for Management Strategies.
    J Am Coll Cardiol. 2025 Nov 26:S0735-1097(25)09988.
    PubMed    
    
    
    
23. MOHAMMADNIA N, Xue L, Vestjens LTW, Uddin MM, et al
    Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial.
    J Am Coll Cardiol. 2025;86:1983-1996.
    PubMed     Abstract available
    
    
    
24. ROSENSON RS, Goonewardena SN
    Remnant Cholesterol and Cardiovascular Risk in Young Adults: Moving Beyond Low-Density Lipoprotein Cholesterol.
    J Am Coll Cardiol. 2025;86:2059-2061.
    PubMed    
    
    
    
25. JUNG HN, Heo JH, Kim MJ, Han KD, et al
    Remnant Cholesterol as an Independent Cardiovascular Risk Factor in Young Adults: An Age-Stratified Cohort Study.
    J Am Coll Cardiol. 2025;86:2047-2058.
    PubMed     Abstract available
    
    
    
26. SPATZ ES
    30-Year Cardiovascular Risk in Comparison With Peers: An Effective Cue to Action?
    J Am Coll Cardiol. 2025;86:2028-2030.
    PubMed    
    
    
    
27. KRISHNAN V, Huang X, Zhang S, Shah NS, et al
    Age and Sex-Specific Percentiles of 30-Year Cardiovascular Disease Risk Based on the PREVENT Equations.
    J Am Coll Cardiol. 2025;86:2017-2027.
    PubMed     Abstract available
    
    
    
28. RAZAVI AC, Blaha MJ, Sperling LS, Whelton SP, et al
    Lp(a) and Inflammation in Cardiovascular Disease: On the Horizon for Risk Assessment and Future Therapies.
    J Am Coll Cardiol. 2025;86:2014-2016.
    PubMed    
    
    
    
29. TARDIF JC, Dube MP
    Does Colchicine Reduce Both Inflammation and Clonal Hematopoiesis in Atherosclerotic Cardiovascular Disease?
    J Am Coll Cardiol. 2025;86:1997-1999.
    PubMed    
    
    
    
30. BALDASSARRE LA, Mendes LA, Blankstein R, Hahn RT, et al
    2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)07261.
    PubMed    
    
    
    
31. OSTROMINSKI JW, Neuen BL, Claggett BL, Filippatos G, et al
    Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10071.
    PubMed    
    
    
    
32. HEIDENREICH PA
    Giga-Trials Support Vaccination as Secondary Prevention for Cardiovascular Disease.
    J Am Coll Cardiol. 2025 Nov 14:S0735-1097(25)09944.
    PubMed    
    
    
    
33. ACQUAH I, Hagan K, Shapiro M, Rikhi RR, et al
    Interplay of Coronary Artery Calcium and PREVENT Equations in Atherosclerotic Cardiovascular Disease Risk Prediction.
    J Am Coll Cardiol. 2025 Nov 12:S0735-1097(25)09464.
    PubMed    
    
    
    
34. LI Z, Doudesis D, Bularga A, Wereski R, et al
    Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department: A Secondary Analysis.
    J Am Coll Cardiol. 2025;86:1738-1748.
    PubMed     Abstract available
    
    
    
35. BHATIA HS, McParland J, Rikhi R, Tsai M, et al
    Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk: MESA and UK Biobank.
    J Am Coll Cardiol. 2025 Nov 10:S0735-1097(25)09481.
    PubMed     Abstract available
    
    
    
36. KRAMER CM, Lewis SJ, Wood MJ
    Transforming Cardiovascular Leadership Through Strategic Investment.
    J Am Coll Cardiol. 2025 Nov 5:S0735-1097(25)09821.
    PubMed    
    
    
    
37. YANG E, Ferdinand KC
    Ushering in a New Approach for Primary Prevention: Guidelines for Assessing Cardiovascular Risk.
    J Am Coll Cardiol. 2025;86:1532-1535.
    PubMed    
    
    
    
38. WU Y, Neal B, Miranda JJ, Labarthe D, et al
    Salt Substitution for Hypertension and Cardiovascular Disease Prevention: The SSaSS Trial and Beyond.
    J Am Coll Cardiol. 2025;86:1504-1506.
    PubMed    
    
    
    October 2025
39. YIN Y, Wang X, Zheng K, Sun T, et al
    Safety and Efficacy of Intensive BP Control in Cardiovascular-Kidney-Metabolic Syndrome: A Post Hoc Analysis of the SPRINT Trial.
    J Am Coll Cardiol. 2025;86:1452-1455.
    PubMed    
    
    
    
40. MCCARTHY CP, McEvoy JW, Brown JM
    PREVENTing Hypertensive Cardiovascular Disease: Where to Draw the Line?
    J Am Coll Cardiol. 2025;86:1449-1451.
    PubMed    
    
    
    
41. DE WINTER RW, Hoek R, Walsh SJ, Hanratty CG, et al
    PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial.
    J Am Coll Cardiol. 2025 Oct 28:S0735-1097(25)09477.
    PubMed     Abstract available
    
    
    
42. AHMAD Y, Reddy RK, Yeh RW
    Beyond technical feasibility in complex percutaneous coronary intervention: lessons on equipoise, evidence and dogma from the PROCTOR Trial.
    J Am Coll Cardiol. 2025 Oct 28:S0735-1097(25)09923.
    PubMed    
    
    
    
43. MEHTA SR, Pinilla-Echeverri N, Tiong D, Kovalova T, et al
    Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial.
    J Am Coll Cardiol. 2025 Oct 25:S0735-1097(25)09815.
    PubMed     Abstract available
    
    
    
44. TIAN Y, Cao X, Wang X, Zheng C, et al
    LDL-C-Related Cardiovascular Burden in China 2010 to 2030: Spatiotemporal Patterns and Scenario-Based Projections.
    J Am Coll Cardiol. 2025 Oct 15:S0735-1097(25)09513.
    PubMed     Abstract available
    
    
    
45. FEZZI S, Serruys PW, Cortese B, Scheller B, et al
    Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement.
    J Am Coll Cardiol. 2025;86:1170-1202.
    PubMed     Abstract available
    
    
    
46. IMBESI A, Greco A, Spagnolo M, Laudani C, et al
    Targeting Inflammation After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2025;86:1146-1169.
    PubMed     Abstract available
    
    
    
47. KHETARPAL SA, Shi Z, Goyal A, Patel AP, et al
    Combining Polygenic Risk With LDL, CRP, and Lp(a) to Predict Coronary Artery Disease: UK Biobank Study.
    J Am Coll Cardiol. 2025 Oct 14:S0735-1097(25)07625.
    PubMed    
    
    
    
48. LOPEZ-AYALA P, Boeddinghaus J, Koechlin L, Bima P, et al
    Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2025 Oct 13:S0735-1097(25)07767.
    PubMed     Abstract available
    
    
    
49. AMPONSAH DK, Elliott A, Harris E, Ramratnam M, et al
    The Underestimated Cardiovascular Research Participant: The U.S. Veteran.
    J Am Coll Cardiol. 2025 Oct 11:S0735-1097(25)07692.
    PubMed    
    
    
    
50. ZHENG C, Wang X, Gu R, Wang W, et al
    The Burden of Cardiovascular Disease in China: Incidence Estimates From National Surveillance (2023).
    J Am Coll Cardiol. 2025 Oct 8:S0735-1097(25)07615.
    PubMed     Abstract available
    
    
    
51. LEE H, Huang X, Khan SS, Son D, et al
    Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease.
    J Am Coll Cardiol. 2025;86:1017-1029.
    PubMed     Abstract available
    
    
    September 2025
52. BERMAN AN, Mukhopadhyay A, Blecker SB, Horwitz LI, et al
    Reimagining Cardiovascular Screening: Leveraging Detection for Population Health Impact.
    J Am Coll Cardiol. 2025;86:959-961.
    PubMed    
    
    
    
53. MENSAH GA, Arnold N, Prabhu SD, Ridker PM, et al
    Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.
    J Am Coll Cardiol. 2025 Sep 29:S0735-1097(25)07555.
    PubMed     Abstract available
    
    
    
54. MASRI A, Judge DP, Ruberg FL, Gillmore JD, et al
    Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM.
    J Am Coll Cardiol. 2025 Sep 28:S0735-1097(25)07774.
    PubMed     Abstract available
    
    
    
55. 
    Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.
    J Am Coll Cardiol. 2025 Sep 24:S0735-1097(25)07428.
    PubMed     Abstract available
    
    
    
56. REYNOLDS HR
    Incidence and Causes of Myocardial Infarction in Younger Women and Men.
    J Am Coll Cardiol. 2025;86:889-891.
    PubMed    
    
    
    
57. ZHAO B, Zhang J, Xie Y, Wu Z, et al
    Intensive vs Conventional Intraoperative Blood Pressure Management on Cardiovascular Events After Major Abdominal Surgery: The BP-CARES Randomized Trial.
    J Am Coll Cardiol. 2025;86:892-906.
    PubMed     Abstract available
    
    
    
58. KRUMHOLZ HM
    Guiding the AI Revolution in Cardiovascular Medicine.
    J Am Coll Cardiol. 2025;86:843-845.
    PubMed    
    
    
    
59. IKEMURA N, Jones PG, Fu Z, Chan PS, et al
    Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease.
    J Am Coll Cardiol. 2025;86:782-793.
    PubMed     Abstract available
    
    
    
60. SAURA O, Hekimian G, Del Marmol G, Lucenteforte M, et al
    Effect of ECMO Flow Variations on Pulmonary Capillary Wedge Pressure in Patients With Cardiogenic Shock.
    J Am Coll Cardiol. 2025;86:768-778.
    PubMed     Abstract available
    
    
    
61. JAIN SS, Mortazavi BJ, Chan You S, Yao X, et al
    Moving Beyond the Model: Our Perspective on Meaningful AI Research in Cardiovascular Care.
    J Am Coll Cardiol. 2025;86:691-695.
    PubMed    
    
    
    
62. PENG AW, Razavi AC, Wilkins JT, Allen NB, et al
    Impact of LDL-Cholesterol When the Coronary Artery Calcium Score Is 0: Long-Term Cardiovascular Events.
    J Am Coll Cardiol. 2025;86:676-680.
    PubMed    
    
    
    August 2025
63. YANG S, Hu X, Zhang J, Jiang J, et al
    Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI: The FLAVOUR Trial Extended Follow-Up.
    J Am Coll Cardiol. 2025;86:593-606.
    PubMed     Abstract available
    
    
    
64. ARUN AS, Sawano M, Lu Y, Warner F, et al
    Update to the JACC Report Card: Excess Cardiovascular Mortality Among Black Americans, 2000-2023.
    J Am Coll Cardiol. 2025;86:559-562.
    PubMed    
    
    
    
65. KHAN SS, Lloyd-Jones DM, Abdalla M, Bello NA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2025 Aug 26:S0735-1097(25)07342.
    PubMed     Abstract available
    
    
    
66. D'ASCENZO F, Cerrato E, De Filippo O, Gaido L, et al
    Computed Tomography Angiography or Standard Care After Left Main PCI?
    J Am Coll Cardiol. 2025 Aug 26:S0735-1097(25)07401.
    PubMed     Abstract available
    
    
    
67. PICCOLO R, Calabro P, Carrara G, Simonetti F, et al
    Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial.
    J Am Coll Cardiol. 2025 Aug 25:S0735-1097(25)07548.
    PubMed     Abstract available
    
    
    
68. EZZAT D, Uddin MM, Xue L, Pershad Y, et al
    Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women.
    J Am Coll Cardiol. 2025 Aug 22:S0735-1097(25)07388.
    PubMed     Abstract available
    
    
    
69. A HEIDENREICH P, Bhatt A, Nazir NT, Schaffner W, et al
    2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Adult Immunizations as Part of Cardiovascular Care: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07089.
    PubMed    
    
    
    
70. RAY KK, Szarek M, Bhatt DL, Bittner VA, et al
    Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07551.
    PubMed    
    
    
    
71. KRUMHOLZ HM, Pagidipati NJ
    Obicetrapib and Cardiovascular Events: A Promising Signal in Need of Confirmation.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07430.
    PubMed    
    
    
    
72. GALLONE G, Baldetti L, Veen KM, Bernhardt AM, et al
    Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07381.
    PubMed     Abstract available
    
    
    
73. OSTROMINSKI JW, Harrington J, Claggett BL, Filippatos G, et al
    Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07505.
    PubMed     Abstract available
    
    
    
74. NICHOLLS SJ, Nelson AJ, Ray KK, Ballantyne CM, et al
    Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07383.
    PubMed     Abstract available
    
    
    
75. BABER U
    Bleeding and Thrombotic Risk After Percutaneous Coronary Intervention: No Longer a Zero-Sum Game.
    J Am Coll Cardiol. 2025;86:499-501.
    PubMed    
    
    
    
76. KADAKIA KT, Dhruva SS, Krumholz HM
    The Role of Clinicians in Advancing Cardiovascular Device Safety.
    J Am Coll Cardiol. 2025;86:481-484.
    PubMed    
    
    
    
77. KIRTANE AJ, Shlofmitz R, Moses J, Bachinsky W, et al
    Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis.
    J Am Coll Cardiol. 2025;86:502-511.
    PubMed     Abstract available
    
    
    
78. HALLER PM, Melloni GEM, Berg DD, Kamanu FK, et al
    A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07028.
    PubMed     Abstract available
    
    
    
79. INOUE S
    Reassessing Clonal Hematopoiesis as a Cardiovascular Risk Factor in Older Women: It's Not Just Age.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07497.
    PubMed    
    
    
    
80. GALLI M, Benenati S, Laudani C, Simeone B, et al
    Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07492.
    PubMed     Abstract available
    
    
    
81. RAPHAEL CE, Sandoval Y, Beachey JD, Roger V, et al
    Causes of Myocardial Infarction in Younger Patients: Troponin-Elevation in Persons
    J Am Coll Cardiol. 2025 Aug 7:S0735-1097(25)07120.
    PubMed     Abstract available
    
    
    
82. KRAMER CM
    Leading With Purpose: ACC's Global Commitment to Cardiovascular Health.
    J Am Coll Cardiol. 2025 Aug 4:S0735-1097(25)07100.
    PubMed    
    
    
    
83. TAN S, Nelson AJ, Muthalaly RG, Nerlekar N, et al
    Pop-Up Cardiovascular Screening Within Community Pharmacies and an International Sporting Event.
    J Am Coll Cardiol. 2025 Aug 4:S0735-1097(25)07177.
    PubMed     Abstract available
    
    
    July 2025
84. MARTINEZ A, Etiwy M, Januzzi JL Jr, McCarthy CP, et al
    Misclassification of Myocardial Infarction Subtypes in Administrative Claims: Implications for Clinical Epidemiology and Quality Assessment.
    J Am Coll Cardiol. 2025;86:284-286.
    PubMed    
    
    
    
85. HAERTEL F, Schulze PC, Davis HR, Weingartner O, et al
    Reducing Cardiovascular Events With Early Ezetimibe: Getting to "Europe on Target" From "Jena auf Ziel".
    J Am Coll Cardiol. 2025;86:e25-e26.
    PubMed    
    
    
    
86. HUANG X, Zhang H, Li Y, Ge J, et al
    Modest Effects of Intensive Blood Pressure-Lowering on Quality of Life in Patients at High Cardiovascular Risk: The ESPRIT trial.
    J Am Coll Cardiol. 2025 Jul 25:S0735-1097(25)06777.
    PubMed     Abstract available
    
    
    
87. NEWMAN JD, Rajagopalan S, Brook RD
    Breathing Easier: Air Filtration to Improve Indoor Air Quality as a Cardiovascular Intervention.
    J Am Coll Cardiol. 2025 Jul 23:S0735-1097(25)06968.
    PubMed    
    
    
    
88. OSTROMINSKI JW, Hirsch JS, Miao B, Clark B, et al
    Risk Factor Control in U.S. Adults With Cardiovascular-Kidney-Metabolic Multimorbidity, 1999-2020.
    J Am Coll Cardiol. 2025;86:217-221.
    PubMed    
    
    
    
89. HE D, Zhang X, Li C, Yang C, et al
    Rising Prevalence of Cardiovascular-Kidney-Metabolic Syndrome in China, 2010-2019: National Cross-Sectional Surveys.
    J Am Coll Cardiol. 2025;86:213-216.
    PubMed    
    
    
    
90. CHO SMJ, Levin M, Chen R, Samarakoon R, et al
    AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations.
    J Am Coll Cardiol. 2025;86:181-192.
    PubMed     Abstract available
    
    
    
91. SCHWARTZ JI, Ssinabulya I, Kayima J, Longenecker CT, et al
    Syndemic Interactions and Cardiovascular Risk Factors: More Than Just a Sum of the Parts.
    J Am Coll Cardiol. 2025;86:178-180.
    PubMed    
    
    
    
92. CHONG B, Jayabaskaran J, Jauhari SM, Chia J, et al
    The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050.
    J Am Coll Cardiol. 2025;86:165-177.
    PubMed     Abstract available
    
    
    
93. WATKINS DA, Pickersgill SJ, Flood D, Gaziano TA, et al
    Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050: A Modeling Study.
    J Am Coll Cardiol. 2025;86:149-161.
    PubMed     Abstract available
    
    
    
94. COVANI M, Niccoli G, Fujimoto D, Scalamera R, et al
    Plaque Vulnerability and Cardiovascular Risk Factor Burden in Acute Coronary Syndrome: An Optical Coherence Tomography Analysis.
    J Am Coll Cardiol. 2025;86:77-89.
    PubMed     Abstract available
    
    
    
95. JOHNSON TW, Bergmark BA, Croce K, Pellegrini D, et al
    Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical Outcomes: An ILUMIEN-IV Substudy.
    J Am Coll Cardiol. 2025;86:93-102.
    PubMed     Abstract available
    
    
    
96. EFTEKHARI A, Jensen LO, Veien K, Raungaard B, et al
    Biolimus-Eluting Biomatrix Stent vs a Dual-Therapy Sirolimus-Eluting Stent in PCI: The SORT OUT XI Randomized Trial.
    J Am Coll Cardiol. 2025;86:106-115.
    PubMed     Abstract available
    
    
    
97. MARQUARD JM, Beske RP, Kelbaek H, Holmvang L, et al
    10-Year Outcome of Complete or Infarct Artery-Only Revascularization in STEMI With Multivessel Disease: The DANAMI-3-PRIMULTI Study.
    J Am Coll Cardiol. 2025;86:119-129.
    PubMed     Abstract available
    
    
    
98. BEN-YEHUDA O
    From Epidemiology to Acute Coronary Syndromes: Risk Factors and Plaque Vulnerability.
    J Am Coll Cardiol. 2025;86:90-92.
    PubMed    
    
    
    
99. AL-LAMEE RK, Zaman S
    Introducing the Lancet Commission on Coronary Artery Disease.
    J Am Coll Cardiol. 2025;86:144-145.
    PubMed    
    
    
    
100. DANGAS K, Kadakia KT, Ferro EG, Song Y, et al
     Outpatient Migration of Cardiovascular Procedures in the United States.
     J Am Coll Cardiol. 2025;86:133-143.
     PubMed    
     
     
     
101. KEREIAKES DJ
     Contemporary Coronary Stents and Noninferiority Clinical Trials.
     J Am Coll Cardiol. 2025;86:116-118.
     PubMed    
     
     
     
102. MILLER PE, Brusca SB, Ko DT, Dhruva SS, et al
     The Potential Role of Early Left Ventricular Unloading in ST-Segment Elevation Myocardial Infarction-Related Cardiogenic Shock.
     J Am Coll Cardiol. 2025;85:2469-2471.
     PubMed    
     
     
     
103. MOLLER JE, Beske RP, Jensen LO, Eiskjaer H, et al
     Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock.
     J Am Coll Cardiol. 2025;85:2456-2468.
     PubMed     Abstract available
     
     
     
104. YAN BW, Arun AS, Curtis LH, Kadakia KT, et al
     JACC Data Report: Cardiovascular Disease Mortality Trends in the United States (1999-2023).
     J Am Coll Cardiol. 2025;85:2495-2498.
     PubMed    
     
     
     
105. JAMIL Y, Krishnaswami A, Orkaby AR, Stimmel M, et al
     The Impact of Cognitive Impairment on Cardiovascular Disease.
     J Am Coll Cardiol. 2025;85:2472-2491.
     PubMed     Abstract available
     
     
     June 2025
106. JANSSEN SLJE, van Everdingen WM, Saalmink WBJ, Lamers SK, et al
     Relationship Between Exercise-Induced Cardiac Troponin Elevations and Occult Coronary Atherosclerosis in Middle-Aged Athletes.
     J Am Coll Cardiol. 2025;85:2370-2382.
     PubMed     Abstract available
     
     
     
107. MCCARTHY CP, Wasfy MM
     Exercise-Induced Troponin Elevation and Coronary Atherosclerosis: Have We Crossed the Finish Line?
     J Am Coll Cardiol. 2025;85:2383-2385.
     PubMed    
     
     
     
108. PATEL SM, Giugliano RP, Morrow DA, Parkar S, et al
     Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71.
     J Am Coll Cardiol. 2025;85:2288-2298.
     PubMed     Abstract available
     
     
     
109. KHAN SS
     Navigating the Long Road Ahead in Cardiovascular Disease Prevention Using the PREVENT Equations.
     J Am Coll Cardiol. 2025;85:2250-2252.
     PubMed    
     
     
     
110. FARIDI KF, Malik D, Essa M, Yang H, et al
     10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population.
     J Am Coll Cardiol. 2025;85:2239-2249.
     PubMed     Abstract available
     
     
     
111. FREED BH, Afari ME, Abideen Asad ZUL, Banerjee D, et al
     Signaling 101 for Cardiovascular Disease Fellowship Recruitment.
     J Am Coll Cardiol. 2025 Jun 17:S0735-1097(25)06768.
     PubMed    
     
     
     
112. GILBERT O, Gulati M, Gluckman TJ, Kittleson MM, et al
     2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee.
     J Am Coll Cardiol. 2025 Jun 16:S0735-1097(25)06504.
     PubMed    
     
     
     
113. KRAMER CM, Echols MR
     Health Equity in Cardiovascular Care: A Clinical Imperative for Better Outcomes.
     J Am Coll Cardiol. 2025 Jun 11:S0735-1097(25)06491.
     PubMed    
     
     
     
114. MURUGIAH K, McDonagh TA, Cohen DJ, Dhruva SS, et al
     Mechanical Circulatory Support in Acute Myocardial Infarction-Cardiogenic Shock: 2025 Acute Coronary Syndrome Guideline in Context.
     J Am Coll Cardiol. 2025;85:2103-2106.
     PubMed    
     
     
     
115. KAUL S
     Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update.
     J Am Coll Cardiol. 2025;85:2096-2099.
     PubMed    
     
     
     
116. FURTADO RHM, Rochitte CE, Nicolau JC, Echeverria LE, et al
     American College of Cardiology/American Heart Association Acute Coronary Syndrome Guidelines: A Latin American Perspective.
     J Am Coll Cardiol. 2025;85:2122-2125.
     PubMed    
     
     
     
117. SAWANO M, Du X, Wong ND, You SC, et al
     The 2025 Guideline for the Management of Patients With Acute Coronary Syndromes: Asian Perspective.
     J Am Coll Cardiol. 2025;85:2114-2117.
     PubMed    
     
     
     
118. BELTRAME JF, Nicholls SJ
     The 2025 ACC/AHA Guideline for Acute Coronary Syndromes: A View From Down Under.
     J Am Coll Cardiol. 2025;85:2111-2113.
     PubMed    
     
     
     
119. BRANDTS J, Ray KK
     Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline: What It Is and What It Might Have Been.
     J Am Coll Cardiol. 2025;85:2107-2110.
     PubMed    
     
     
     
120. RIDKER PM
     Colchicine for Cardiovascular Disease: Navigating the Gap Between Evidence, Guidelines, and Clinical Practice.
     J Am Coll Cardiol. 2025;85:2092-2095.
     PubMed    
     
     
     
121. KO DT, Al-Lamee RK, Bikdeli B, Cohen DJ, et al
     Perspective on the Choice and Duration of Dual Antiplatelet Therapy Recommendations in the 2025 Acute Coronary Syndrome Management Guideline.
     J Am Coll Cardiol. 2025;85:2079-2082.
     PubMed    
     
     
     
122. BIKDELI B, Ujueta F, Rashedi S, Talasaz AH, et al
     Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations.
     J Am Coll Cardiol. 2025;85:2074-2078.
     PubMed    
     
     
     
123. RAO SV
     The 2025 American College of Cardiology/American Heart Association Acute Coronary Syndrome Guideline: A Personal Perspective.
     J Am Coll Cardiol. 2025;85:2068-2070.
     PubMed    
     
     
     
124. ANTMAN EM, Braunwald E
     Acute Coronary Syndromes: A Holistic View.
     J Am Coll Cardiol. 2025;85:2057-2060.
     PubMed    
     
     
     
125. BUDDE RPJ, Faure ME, Abbara S, Alkadhi H, et al
     Cardiac Computed Tomography for Prosthetic Heart Valve Assessment: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the European Society of Cardiovascular Radiology (ES
     J Am Coll Cardiol. 2025 Jun 10:S0735-1097(25)06617.
     PubMed     Abstract available
     
     
     
126. BARKAS F, Brandts J, De Bacquer D, Jennings C, et al
     Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies.
     J Am Coll Cardiol. 2025;85:2028-2042.
     PubMed     Abstract available
     
     
     
127. ERLINGE D, Tsimikas S, Maeng M, Maehara A, et al
     Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.
     J Am Coll Cardiol. 2025;85:2011-2024.
     PubMed     Abstract available
     
     
     May 2025
128. SCHWARTZ GG, Cobbaert CM
     Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications.
     J Am Coll Cardiol. 2025;85:1855-1857.
     PubMed    
     
     
     
129. MARK DB, Nanna MG, Douglas PS
     Connecting Anatomic Coronary Disease and Functional Ischemia With Treatment of Patient-Reported Angina: A Jigsaw Puzzle of Surprising Complexity.
     J Am Coll Cardiol. 2025;85:1754-1756.
     PubMed    
     
     
     
130. AHMED-JUSHUF F, Foley MJ, Rajkumar CA, Chotai S, et al
     Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial.
     J Am Coll Cardiol. 2025;85:1740-1753.
     PubMed     Abstract available
     
     
     
131. IKEMURA N, Chan PS, Cohen DJ, Kennedy KF, et al
     Trends and Physician-Level Variation in Contrast Volume During Percutaneous Coronary Intervention: Insights From the NCDR CathPCI Registry.
     J Am Coll Cardiol. 2025;85:1792-1795.
     PubMed    
     
     
     
132. BONGIOVANNI D, Landi A, Frigoli E, Heg D, et al
     Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR Patient.
     J Am Coll Cardiol. 2025 May 7:S0735-1097(25)06483.
     PubMed     Abstract available
     
     
     April 2025
133. WITTELES RM, Garcia-Pavia P, Damy T, Grogan M, et al
     Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy: HELIOS-B.
     J Am Coll Cardiol. 2025 Apr 30:S0735-1097(25)06170.
     PubMed     Abstract available
     
     
     
134. CHOW CK, Archer O, Kritharides L
     Should Patients With Myocardial Infarction Be Started on Combination Therapy With Ezetimibe Before Hospital Discharge?
     J Am Coll Cardiol. 2025;85:1565-1567.
     PubMed    
     
     
     
135. LEOSDOTTIR M, Schubert J, Brandts J, Gustafsson S, et al
     Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.
     J Am Coll Cardiol. 2025;85:1550-1564.
     PubMed     Abstract available
     
     
     
136. KRUMHOLZ HM
     Black Lives and Cardiovascular Deaths.
     J Am Coll Cardiol. 2025;85:1576-1577.
     PubMed    
     
     
     
137. SHARMA G, Powell-Wiley TM, Brazile TL
     Maternal Obesity and Adverse Pregnancy Outcomes as Mediators of Cardiovascular Disease Risk in Midlife.
     J Am Coll Cardiol. 2025;85:1547-1549.
     PubMed    
     
     
     
138. BORROWMAN JD, Huang X, Petito LC, Perak AM, et al
     Prepregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife.
     J Am Coll Cardiol. 2025;85:1536-1546.
     PubMed     Abstract available
     
     
     
139. WILLIAMS MS, Levine GN, Kalra D, Agarwala A, et al
     2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
     J Am Coll Cardiol. 2025 Apr 22:S0735-1097(25)00282.
     PubMed     Abstract available
     
     
     
140. MATHEW V, Khan RR, Jowell AR, Yan Q, et al
     Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women.
     J Am Coll Cardiol. 2025;85:1488-1500.
     PubMed     Abstract available
     
     
     
141. MCCARTHY CP, McEvoy JW, Januzzi JL Jr
     Troponin Testing for Cardiovascular Primary Prevention Decision Making?
     J Am Coll Cardiol. 2025;85:1485-1487.
     PubMed    
     
     
     
142. SHAH ASV, Keene SJ, Pennells L, Kaptoge S, et al
     Cardiac Troponins and Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.
     J Am Coll Cardiol. 2025;85:1471-1484.
     PubMed     Abstract available
     
     
     
143. BIGA C, Blackwell J, Bradley SM, Lakkireddy D, et al
     Translating Guidance Into Practice: The Final Common Pathway in Cardiovascular Care Delivery.
     J Am Coll Cardiol. 2025 Apr 15:S0735-1097(25)06007.
     PubMed    
     
     
     
144. KRAMER CM
     My Fantastic Voyage: Innovation, Mentorship, and the Future of Cardiovascular Medicine.
     J Am Coll Cardiol. 2025 Apr 15:S0735-1097(25)06119.
     PubMed    
     
     
     
145. SU Q, Zeng X
     The Role of Geriatric Expertise on Cardiovascular Outcomes When Cardiologists Are Employed by Hospitals.
     J Am Coll Cardiol. 2025 Apr 10:S0735-1097(25)05902.
     PubMed    
     
     
     
146. KADAKIA KT, Krumholz HM
     FDA's Proposed Nicotine Regulations: A New Frontier for Cardiovascular Health.
     J Am Coll Cardiol. 2025;85:1459-1461.
     PubMed    
     
     
     
147. DEAN PN, Brothers JA, Burns K, Edelson JB, et al
     The Cardiovascular Care of the Pediatric Athlete.
     J Am Coll Cardiol. 2025;85:1434-1454.
     PubMed     Abstract available
     
     
     
148. BANGALORE S, Mancini GBJ, Leipsic J, Budoff MJ, et al
     Invasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA Trial.
     J Am Coll Cardiol. 2025;85:1335-1349.
     PubMed     Abstract available
     
     
     
149. MARON DJ, Newman JD, Anthopolos R, Lu Y, et al
     Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.
     J Am Coll Cardiol. 2025;85:1317-1331.
     PubMed     Abstract available
     
     
     
150. VAUGHAN LE, Garovic VD
     Reply: Social Work Interventions to Reduce Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy.
     J Am Coll Cardiol. 2025;85:e131.
     PubMed    
     
     
     
151. ZHOU R, Ye S, Liu J, Duan L, et al
     Social Work Interventions to Reduce Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy.
     J Am Coll Cardiol. 2025;85:e129-e130.
     PubMed    
     
     
     March 2025
152. SHURRAB M, Ko DT
     Fewer Drugs, Less Bleeding in Atrial Fibrillation With Stable Coronary Artery Disease: Less Is More.
     J Am Coll Cardiol. 2025;85:1204-1206.
     PubMed    
     
     
     
153. KUVIN JT, Sibley J, Kramer CM, Biga C, et al
     The Winding Road to an Independent Cardiovascular Board: Where Do We Go From Here?
     J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05897.
     PubMed    
     
     
     
154. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
     The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
     J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05281.
     PubMed    
     
     
     
155. BLOM DJ, Gaudet D
     Beyond LDL: Targeting ANGPTL3 to Reduce Residual Cardiovascular Risk.
     J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05927.
     PubMed    
     
     
     
156. MORICI N, Sacco A, Frea S, Rota M, et al
     Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial.
     J Am Coll Cardiol. 2025 Mar 21:S0735-1097(25)05334.
     PubMed     Abstract available
     
     
     
157. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
     Lipoprotein(a) Cardiovascular Risk Explained by LDL Cholesterol, Non-HDL Cholesterol, ApoB, or hsCRP Is Minimal.
     J Am Coll Cardiol. 2025 Mar 19:S0735-1097(25)00484.
     PubMed    
     
     
     
158. MCGRAW KE, Shea S, Navas-Acien A, Sanchez TR, et al
     Reply: Urinary Metal Levels and Coronary Artery Calcification: Potential Confounders.
     J Am Coll Cardiol. 2025;85:e111.
     PubMed    
     
     
     
159. WU J, Zhang Z, Zhang L
     Environmental Metal Exposure and Cardiovascular Disease Risk.
     J Am Coll Cardiol. 2025;85:e109.
     PubMed    
     
     
     
160. CHAZAL RA, Lopez-Mattei J, Gaztanaga J
     Urinary Metal Levels and Coronary Artery Calcification: Potential Confounders.
     J Am Coll Cardiol. 2025;85:e107.
     PubMed    
     
     
     
161. GRONDIN S, Neveu B, Soltani I, Alaoui AA, et al
     Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study.
     J Am Coll Cardiol. 2025;85:988-999.
     PubMed     Abstract available
     
     
     
162. TANG GHL
     The Value of Case-Based Learning in Cardiovascular Medicine.
     J Am Coll Cardiol. 2025;85:1058.
     PubMed    
     
     
     
163. GALVIN O, Nasir K, McEvoy JW
     The Cardiovascular Epidemiology of Smoking: Past, Present, and Future.
     J Am Coll Cardiol. 2025;85:1035-1037.
     PubMed    
     
     
     
164. YAO Z, Tasdighi E, Dardari ZA, Jha KK, et al
     Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular Harm.
     J Am Coll Cardiol. 2025;85:1018-1034.
     PubMed     Abstract available
     
     
     
165. JUDGE DP, Alexander KM, Cappelli F, Fontana M, et al
     Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy.
     J Am Coll Cardiol. 2025;85:1003-1014.
     PubMed     Abstract available
     
     
     
166. LAWS JL, Davogustto GE, Wells QS
     Genetic Testing for Cardiovascular Disease: Evidence Grows But Challenges Remain.
     J Am Coll Cardiol. 2025;85:1000-1002.
     PubMed    
     
     
     
167. CHU L, Chen K
     Understanding the Cardiovascular Impacts of Heatwaves: Moving Beyond Simple Definitions.
     J Am Coll Cardiol. 2025 Mar 17:S0735-1097(25)00365.
     PubMed    
     
     
     
168. ESSA M, Decker SRR, Liang L, Song Y, et al
     Use of Cardiac Rehabilitation in Older Patients with Myocardial Infarction Complicated by Cardiogenic Shock.
     J Am Coll Cardiol. 2025 Mar 12:S0735-1097(25)05893.
     PubMed    
     
     
     
169. CANTEY EP, Lopacinski A, Seth M, Hamilton DE, et al
     Managing Cardiogenic Shock Caused by Acute Myocardial Infarction: Invisible Challenges Revealed in a Statewide Registry.
     J Am Coll Cardiol. 2025 Mar 10:S0735-1097(25)05209.
     PubMed    
     
     
     
170. LASSEN MCH, Modin D, Johansen ND, Sivapalan P, et al
     Respiratory Syncytial Virus and Incidence of Cardiovascular Events: A Nationwide Self-Controlled Case Series Analysis.
     J Am Coll Cardiol. 2025 Mar 10:S0735-1097(25)05260.
     PubMed    
     
     
     
171. BHATT AB, Biesbrock GK, Biga C
     Best Practices for Transforming Cardiovascular Care Delivery and Implementation: A Modern Framework.
     J Am Coll Cardiol. 2025 Mar 10:S0735-1097(25)00468.
     PubMed    
     
     
     
172. VARTIAINEN PJ, Huang Y, Sawano M
     More Than an Infant's Respiratory Illness: The Unfolding Cardiovascular Consequences of RSV in Older Adults.
     J Am Coll Cardiol. 2025 Mar 6:S0735-1097(25)05338.
     PubMed    
     
     
     
173. KRUMHOLZ HM, Mori M, Geirsson A
     The Essential Role of Cardiovascular Surgery in Cardiology: A Perspective From JACC.
     J Am Coll Cardiol. 2025;85:785-787.
     PubMed    
     
     
     February 2025
174. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2025 Feb 27:S0735-1097(24)10424.
     PubMed     Abstract available
     
     
     
175. KUMBHANI DJ, Cibotti-Sun M, Moore MM
     2025 Acute Coronary Syndromes Guideline-at-a-Glance.
     J Am Coll Cardiol. 2025 Feb 27:S0735-1097(25)00202.
     PubMed    
     
     
     
176. YANG H, Huang C, Sawano M, Herrin J, et al
     Systolic Blood Pressure and Cardiovascular Mortality in U.S. Adults Aged 80+ Taking Antihypertensive Medications.
     J Am Coll Cardiol. 2025 Feb 26:S0735-1097(25)00335.
     PubMed    
     
     
     
177. HESPE S, Waddell A, Asatryan B, Owens E, et al
     Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel.
     J Am Coll Cardiol. 2025;85:727-740.
     PubMed     Abstract available
     
     
     
178. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     J Am Coll Cardiol. 2025 Feb 20:S0735-1097(24)10722.
     PubMed     Abstract available
     
     
     
179. BIGA C, Narula J
     Strengthening Global Partnerships to Combat Cardiovascular Disease: A Call to Action.
     J Am Coll Cardiol. 2025 Feb 19:S0735-1097(25)00203.
     PubMed    
     
     
     
180. NG P, Maehara A, Kirtane AJ, McEntegart M, et al
     Management of Coronary Stent Underexpansion.
     J Am Coll Cardiol. 2025;85:625-644.
     PubMed     Abstract available
     
     
     
181. KLEIN A, Beske RP, Hassager C, Jensen LO, et al
     Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?
     J Am Coll Cardiol. 2025;85:595-603.
     PubMed     Abstract available
     
     
     
182. YEH RW, Bertrand OF, Mahmud E, Barbato E, et al
     Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial.
     J Am Coll Cardiol. 2025;85:563-574.
     PubMed     Abstract available
     
     
     
183. KRUMHOLZ HM, Wallach JD
     Preprints: A Revolution in Cardiovascular Science.
     J Am Coll Cardiol. 2025;85:652-654.
     PubMed    
     
     
     
184. ONG C, Caceres BA
     Altering Adverse Social Determinants of Cardiovascular Health in Sexual Minorities.
     J Am Coll Cardiol. 2025;85:526-527.
     PubMed    
     
     
     
185. SATTI DI, Chan JSK, Mszar R, Mehta A, et al
     Social Determinants of Health, Cardiovascular Health, and Mortality in Sexual Minority Individuals in the United States.
     J Am Coll Cardiol. 2025;85:515-525.
     PubMed     Abstract available
     
     
     
186. MYHRE PL, Vaduganathan M
     Does the Mechanism of Weight Loss Matter for Cardiovascular Protection?
     J Am Coll Cardiol. 2025;85:501-503.
     PubMed    
     
     
     
187. ONUMA OK
     Making Secondary Prevention the Primary Focus for Cardiovascular Disease Control.
     J Am Coll Cardiol. 2025;85:451-453.
     PubMed    
     
     
     
188. CHATURVEDI A, Prabhakaran D
     PURE Evidence in Plain Sight: The Highs, Lows, and Gaps in Secondary Cardiovascular Prevention.
     J Am Coll Cardiol. 2025;85:448-450.
     PubMed    
     
     
     
189. MOGHTADERI A, Magid DJ, Yuan AY, Black B, et al
     The Association of Hospital-Cardiologist Integration With Patient Outcomes, Care Quality, and Utilization.
     J Am Coll Cardiol. 2025;85:352-361.
     PubMed     Abstract available
     
     
     
190. ZAHGER D, Schwartz GG, Szarek M, Fazio S, et al
     Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution.
     J Am Coll Cardiol. 2025;85:e55.
     PubMed    
     
     
     
191. PACKARD CJ, Boren J, John Chapman M
     Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution.
     J Am Coll Cardiol. 2025;85:e53-e54.
     PubMed    
     
     
     January 2025
192. KRUMHOLZ HM
     Tricuspid Valve Interventions: A New Era in Cardiovascular Innovation.
     J Am Coll Cardiol. 2025;85:203-205.
     PubMed    
     
     
     
193. BUCHOLZ EM, Costello JM
     Redefining Outcomes in Pediatric Cardiovascular Research: The Promise of Days Alive Out of Health Care.
     J Am Coll Cardiol. 2025 Jan 24:S0735-1097(25)00019.
     PubMed    
     
     
     
194. TANNU M, Lopes RD, Wojdyla DM, Goodman SG, et al
     Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS.
     J Am Coll Cardiol. 2025 Jan 24:S0735-1097(24)10555.
     PubMed     Abstract available
     
     
     
195. CHEN K, Lu Y, Krumholz HM
     Wildfires, Compound Extreme Events, Climate Change, and Cardiovascular Health.
     J Am Coll Cardiol. 2025 Jan 21:S0735-1097(25)00136.
     PubMed    
     
     
     
196. SCHNEIDER A, Chen K, Breitner S
     The Pathogenetic Link Between Ozone Pollution and Cardiovascular Disease.
     J Am Coll Cardiol. 2025 Jan 17:S0735-1097(24)10658.
     PubMed    
     
     
     
197. RASHEDI S, Keykhaei M, Sato A, Steg PG, et al
     Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials.
     J Am Coll Cardiol. 2025 Jan 17:S0735-1097(25)00071.
     PubMed     Abstract available
     
     
     
198. BEN-YEHUDA O, Mahmud E
     Complete Revascularization Wins in ST-Segment Elevation Myocardial Infarction, But Timing Remains Flexible.
     J Am Coll Cardiol. 2025;85:39-41.
     PubMed    
     
     
     
199. UEYAMA HA, Akita K, Kiyohara Y, Takagi H, et al
     Optimal Strategy for Complete Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Network Meta-Analysis.
     J Am Coll Cardiol. 2025;85:19-38.
     PubMed     Abstract available
     
     
     
200. GAO X, Tian N, Kan J, Li P, et al
     Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial.
     J Am Coll Cardiol. 2025;85:1-15.
     PubMed     Abstract available
     
     
     December 2024
201. MUNZEL T, Kuntic M, Stamm P, Schmidt F, et al
     The High Stakes of High Decibels: The Cardiovascular Fallout From Aircraft Noise.
     J Am Coll Cardiol. 2024 Dec 18:S0735-1097(24)10058.
     PubMed    
     
     
     
202. VAN ROYEN FS, Venekamp RP, Bruijning-Verhagen PCJL, Rutten FH, et al
     Acute Respiratory Infections Fuel Cardiovascular Disease.
     J Am Coll Cardiol. 2024;84:2468-2470.
     PubMed    
     
     
     
203. TOPRICEANU CC, Gong X, Shah M, Shiwani H, et al
     Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI.
     J Am Coll Cardiol. 2024 Dec 13:S0735-1097(24)09797.
     PubMed     Abstract available
     
     
     
204. THORN SL, Spinale FG, Sinusas AJ
     Imaging Fibroblast Activation Protein: Direct Visualization of Matrix Proteolytic Activity in Patients Post Myocardial Infarction.
     J Am Coll Cardiol. 2024 Dec 12:S0735-1097(24)10524.
     PubMed    
     
     
     
205. GIUSTINO G, Sabik JF 3rd, Serruys PW, Puskas JD, et al
     Major Bleeding and Mortality After Revascularization of Left Main Disease.
     J Am Coll Cardiol. 2024;84:2335-2346.
     PubMed     Abstract available
     
     
     
206. WARRAICH HJ, Krumholz HM, Califf RM
     Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC.
     J Am Coll Cardiol. 2024 Dec 10:S0735-1097(24)10509.
     PubMed    
     
     
     
207. GYLDENKERNE C, Kahlert J, Thrane PG, Olesen KKW, et al
     2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.
     J Am Coll Cardiol. 2024;84:2251-2259.
     PubMed     Abstract available
     
     
     November 2024
208. BIGA C, Al Mahmeed W
     The Importance of Growing the Next Generation of Global Cardiovascular Leaders.
     J Am Coll Cardiol. 2024 Nov 27:S0735-1097(24)10425.
     PubMed    
     
     
     
209. NORLAND K, Schaid DJ, Naderian M, Na J, et al
     Associations of Self-Reported Race, Social Determinants of Health, and Polygenic Risk With Coronary Heart Disease.
     J Am Coll Cardiol. 2024;84:2157-2166.
     PubMed     Abstract available
     
     
     
210. SANTOS-PARDO I, Andersson Franko M, Nystrom T
     Reply: Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
     J Am Coll Cardiol. 2024;84:e321.
     PubMed    
     
     
     
211. LIU C, Li X, Cong H
     Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
     J Am Coll Cardiol. 2024;84:e319-e320.
     PubMed    
     
     
     
212. SHAH NS
     Considering Social and Genetic Factors in Cardiovascular Disease Risk.
     J Am Coll Cardiol. 2024;84:2167-2169.
     PubMed    
     
     
     
213. BARTON AK, Craig NJ, Loganath K, Joshi S, et al
     Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study.
     J Am Coll Cardiol. 2024 Nov 26:S0735-1097(24)10315.
     PubMed     Abstract available
     
     
     
214. BIGA C, Rose GA
     Navigating Cardiovascular Employment Trends.
     J Am Coll Cardiol. 2024;84:2150-2153.
     PubMed    
     
     
     
215. KIM JM, Yeh RW, Secemsky EA
     What Is the Rush?: Optimizing the Timing of P2Y(12) Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes.
     J Am Coll Cardiol. 2024 Nov 13:S0735-1097(24)10300.
     PubMed    
     
     
     
216. SANDNER S, Gaudino M
     Reply: Understanding Disparities in Coronary Artery Bypass Surgery Outcomes.
     J Am Coll Cardiol. 2024;84:e297.
     PubMed    
     
     
     
217. HOU R, Ren J
     Gender Disparities in Cardiovascular Literature: Expanding the Scope and Solutions.
     J Am Coll Cardiol. 2024;84:e279.
     PubMed    
     
     
     
218. CUNNINGHAM JW, Abraham WT, Bhatt AS, Dunn J, et al
     Artificial Intelligence in Cardiovascular Clinical Trials.
     J Am Coll Cardiol. 2024;84:2051-2062.
     PubMed     Abstract available
     
     
     
219. AJUFO E, Kany S, Ramo JT, Churchill TW, et al
     Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease.
     J Am Coll Cardiol. 2024 Nov 11:S0735-1097(24)09920.
     PubMed     Abstract available
     
     
     
220. BLUMENTHAL DM, Hsu J
     Understanding The Impact of Vertical Integration on Cardiovascular Care Quality: A Complex and Worthwhile Endeavor.
     J Am Coll Cardiol. 2024 Nov 8:S0735-1097(24)10428.
     PubMed    
     
     
     
221. EATON CB
     Sedentary Behavior and Risk of Cardiovascular Disease.
     J Am Coll Cardiol. 2024 Nov 8:S0735-1097(24)10415.
     PubMed    
     
     
     
222. UEYAMA HA, Kennedy KF, Rymer JA, Sandhu AT, et al
     P2Y(12) Inhibitor Pretreatment in Non-ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry.
     J Am Coll Cardiol. 2024 Nov 7:S0735-1097(24)09843.
     PubMed     Abstract available
     
     
     
223. VERMA S, Emerson S, Plutzky J, Kahn SE, et al
     Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity.
     J Am Coll Cardiol. 2024 Nov 6:S0735-1097(24)10422.
     PubMed    
     
     
     
224. PATEL KV, Chunawala Z, Verma S, Segar MW, et al
     Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study.
     J Am Coll Cardiol. 2024 Nov 5:S0735-1097(24)10417.
     PubMed     Abstract available
     
     
     
225. VAUGHAN LE, Kanaji Y, Suvakov S, Parashuram S, et al
     Hypertensive Disorders of Pregnancy Increase the Risk for Myocardial Infarction: A Population-Based Study.
     J Am Coll Cardiol. 2024 Nov 2:S0735-1097(24)09771.
     PubMed     Abstract available
     
     
     
226. HONIGBERG MC
     Classification of Myocardial Infarction in Women With Hypertensive Disorders of Pregnancy.
     J Am Coll Cardiol. 2024 Nov 1:S0735-1097(24)09773.
     PubMed    
     
     
     October 2024
227. CHEN Z, Vieira de Oliveira Salerno PR, Dazard JE, Kumar Sirasapalli S, et al
     AI-Facilitated Assessment of Built Environment Using Neighborhood Satellite Imagery and Cardiovascular Risk.
     J Am Coll Cardiol. 2024;84:1733-1744.
     PubMed     Abstract available
     
     
     
228. WASFY JH, Januzzi JL Jr
     The Long Pathway to Improving Clinical Decisions With Better Risk Markers: Recurrent Thrombosis After Myocardial Infarction.
     J Am Coll Cardiol. 2024;84:1730-1732.
     PubMed    
     
     
     
229. SCHNEIDER DJ, McMahon SR, Angiolillo DJ, Fanaroff A, et al
     Platelet FcgammaRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction.
     J Am Coll Cardiol. 2024;84:1721-1729.
     PubMed     Abstract available
     
     
     
230. GALLI M, Cortellini G, Occhipinti G, Rossini R, et al
     Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular Disease.
     J Am Coll Cardiol. 2024;84:1748-1766.
     PubMed     Abstract available
     
     
     
231. JAMES P
     Using Artificial Intelligence to Derive Environmental Drivers of Cardiovascular Risk: Is it Intelligent Enough?
     J Am Coll Cardiol. 2024;84:1745-1747.
     PubMed    
     
     
     
232. SAKAI K, Shin D, Singh M, Malik S, et al
     Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease.
     J Am Coll Cardiol. 2024 Oct 23:S0735-1097(24)09956.
     PubMed     Abstract available
     
     
     
233. MARINACCI LX, Zheng Z, Mein S, Wadhera RK, et al
     Rural-Urban Differences in Cardiovascular Mortality in the United States, 2010-2022.
     J Am Coll Cardiol. 2024 Oct 23:S0735-1097(24)09779.
     PubMed    
     
     
     
234. CAVENDER MA
     Optimizing Outcomes in ST-Segment Elevation Myocardial Infarction: Is Prolonged Infusion of Bivalirudin Part of the Solution?
     J Am Coll Cardiol. 2024;84:1525-1527.
     PubMed    
     
     
     
235. STONE GW, Valgimigli M, Erlinge D, Han Y, et al
     Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results.
     J Am Coll Cardiol. 2024;84:1512-1524.
     PubMed     Abstract available
     
     
     
236. FUSTER V, Garcia-Alvarez A, Devesa A, Mass V, et al
     Influence of Subclinical Atherosclerosis Burden and Progression on Mortality.
     J Am Coll Cardiol. 2024;84:1391-1403.
     PubMed     Abstract available
     
     
     
237. YOU SC, Yao X, Bikdeli B, Spatz ES, et al
     Embracing Change: Human-Centered Cardiovascular Medicine in the Era of AI.
     J Am Coll Cardiol. 2024;84:1495-1497.
     PubMed    
     
     
     
238. BJORNSON E, Adiels M, Gummesson A, Taskinen MR, et al
     Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.
     J Am Coll Cardiol. 2024;84:1328-1338.
     PubMed     Abstract available
     
     
     
239. MIERES JH, Douglass PL
     RESPONSE: DEI in the CV Workforce: Foundational for Cardiovascular Care and Critical for Improving Outcomes.
     J Am Coll Cardiol. 2024;84:1370-1371.
     PubMed    
     
     
     
240. ZOCCALI C, Mallamaci F
     Can the Excess Cardiovascular Risk Caused by Chronic Kidney Disease Be Canceled Out?
     J Am Coll Cardiol. 2024;84:1325-1327.
     PubMed    
     
     
     
241. GENG T, Xu W, Gao H, Zhang J, et al
     Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults.
     J Am Coll Cardiol. 2024;84:1313-1324.
     PubMed     Abstract available
     
     
     September 2024
242. BIGA C
     Our Collective Role in Cardiovascular Advocacy.
     J Am Coll Cardiol. 2024 Sep 29:S0735-1097(24)08458.
     PubMed    
     
     
     
243. JAVAHERI S, Javaheri S, Gozal D, Campos-Rodriguez F, et al
     Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2024;84:1224-1240.
     PubMed     Abstract available
     
     
     
244. JAVAHERI S, Javaheri S, Somers VK, Gozal D, et al
     Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2024;84:1208-1223.
     PubMed     Abstract available
     
     
     
245. BHAVE NM, Cibotti-Sun M, Moore MM
     2024 Perioperative Cardiovascular Management for Noncardiac Surgery Guideline-at-a-Glance.
     J Am Coll Cardiol. 2024 Sep 23:S0735-1097(24)08173.
     PubMed    
     
     
     
246. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
     2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     J Am Coll Cardiol. 2024 Sep 23:S0735-1097(24)07611.
     PubMed     Abstract available
     
     
     
247. AL-KINDI S, Nasir K, Rajagopalan S
     Elemental Risk: Role of Metals in Cardiovascular Disease Risk.
     J Am Coll Cardiol. 2024 Sep 12:S0735-1097(24)07985.
     PubMed    
     
     
     
248. MCGRAW KE, Schilling K, Glabonjat RA, Galvez-Fernandez M, et al
     Urinary Metal Levels and Coronary Artery Calcification: Longitudinal Evidence in the Multi-Ethnic Study of Atherosclerosis.
     J Am Coll Cardiol. 2024 Sep 12:S0735-1097(24)07961.
     PubMed     Abstract available
     
     
     
249. ZAHGER D, Schwartz GG, Du W, Szarek M, et al
     Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome.
     J Am Coll Cardiol. 2024;84:994-1006.
     PubMed     Abstract available
     
     
     
250. TOTH PP
     Triglycerides and Cardiovascular Risk: Getting to the Heart of the Matter.
     J Am Coll Cardiol. 2024;84:1007-1009.
     PubMed    
     
     
     
251. YANG E, Bhatt DL, Atwater B
     Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2024;84:886-888.
     PubMed    
     
     
     
252. BERWANGER O, Wojdyla DM, Fanaroff AC, Budaj A, et al
     Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS.
     J Am Coll Cardiol. 2024;84:875-885.
     PubMed     Abstract available
     
     
     
253. EVERETT BM, Wexler DJ
     Finding Truth in Observational and Interventional Studies in Diabetes and Cardiovascular Disease.
     J Am Coll Cardiol. 2024;84:918-920.
     PubMed    
     
     
     
254. KHERA R, Aminorroaya A, Dhingra LS, Thangaraj PM, et al
     Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.
     J Am Coll Cardiol. 2024;84:904-917.
     PubMed     Abstract available
     
     
     August 2024
255. VERMA S, Colhoun HM, Dicker D, Hovingh GK, et al
     Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.
     J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08194.
     PubMed    
     
     
     
256. KANG DY, Lee SH, Lee SW, Lee CH, et al
     Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
     J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08196.
     PubMed     Abstract available
     
     
     
257. HAMMERSLEY DJ, Zegard A, Androulakis E, Jones RE, et al
     Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy.
     J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08109.
     PubMed     Abstract available
     
     
     
258. MANUBOLU VS, Lakshmanan S, Kinninger A, Ahmad K, et al
     Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes: Insights From the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) Randomized Trial.
     J Am Coll Cardiol. 2024;84:865-867.
     PubMed    
     
     
     
259. NEUEN BL, Ostrominski JW, Claggett B, Beldhuis IE, et al
     Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes.
     J Am Coll Cardiol. 2024 Aug 26:S0735-1097(24)08155.
     PubMed    
     
     
     
260. COCCO M, Campo G, Guiducci V, Casella G, et al
     Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation.
     J Am Coll Cardiol. 2024 Aug 25:S0735-1097(24)07984.
     PubMed     Abstract available
     
     
     
261. KRUMHOLZ HM, Geraldes F, Wilson C, Horton R, et al
     The Lancet-JACC Collaboration: Advancing Cardiovascular Health.
     J Am Coll Cardiol. 2024 Aug 24:S0735-1097(24)08240.
     PubMed    
     
     
     
262. AHMAD Y, Reddy RK, Mehta SR
     Myocardial Infarction and Multivessel Disease: Completing the Story.
     J Am Coll Cardiol. 2024 Aug 22:S0735-1097(24)08157.
     PubMed    
     
     
     
263. ANGIOLILLO DJ
     Management of Antiplatelet Therapy After Coronary Stenting in Patients Requiring Non-Cardiac Surgery.
     J Am Coll Cardiol. 2024 Aug 22:S0735-1097(24)08251.
     PubMed    
     
     
     
264. DOHERTY JU, Daugherty SL, Kort S, London MJ, et al
     ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery.
     J Am Coll Cardiol. 2024 Aug 21:S0735-1097(24)07963.
     PubMed    
     
     
     
265. HINKOV H, Greve D, Lee CB, Klein C, et al
     Combined Surgical and Percutaneous Management of Circumflex Artery Occlusion After Minimally Invasive Mitral Valve Repair.
     J Am Coll Cardiol. 2024;84:766-770.
     PubMed     Abstract available
     
     
     
266. MONTONE RA, Rinaldi R, Niccoli G, Ando G, et al
     Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions.
     J Am Coll Cardiol. 2024;84:744-760.
     PubMed     Abstract available
     
     
     
267. CLERICO A, Aimo A, Passino C
     Point-of-Care High-Sensitivity Troponin Testing in the Emergency Department: The Way of the Future?
     J Am Coll Cardiol. 2024;84:741-743.
     PubMed    
     
     
     
268. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Reber C, et al
     Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay.
     J Am Coll Cardiol. 2024;84:726-740.
     PubMed     Abstract available
     
     
     
269. NEUEN BL, Solomon SD
     Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes.
     J Am Coll Cardiol. 2024;84:709-711.
     PubMed    
     
     
     
270. EDMONSTON D, Mulder H, Lydon E, Chiswell K, et al
     Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.
     J Am Coll Cardiol. 2024;84:696-708.
     PubMed     Abstract available
     
     
     
271. AHMAD T, Desai NR, Tabtabai S
     Cardiovascular Care in the United States: Penny Wise and Pound Foolish.
     J Am Coll Cardiol. 2024;84:694-695.
     PubMed    
     
     
     
272. GIBSON CM, Chi G, Duffy D, Bahit MC, et al
     ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
     J Am Coll Cardiol. 2024 Aug 20:S0735-1097(24)08038.
     PubMed     Abstract available
     
     
     
273. NI W, Stafoggia M, Zhang S, Ljungman P, et al
     Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden.
     J Am Coll Cardiol. 2024 Aug 19:S0735-1097(24)07842.
     PubMed     Abstract available
     
     
     
274. CHADALAVADA S, Fung K, Rauseo E, Lee AM, et al
     Myocardial Strain Measured by Cardiac Magnetic Resonance Predicts Cardiovascular Morbidity and Death.
     J Am Coll Cardiol. 2024;84:648-659.
     PubMed     Abstract available
     
     
     
275. CHEN K, Nasir K
     Balancing the Climate Equation: The Unseen Cardiovascular Threat of Cold Spells in a Warming World.
     J Am Coll Cardiol. 2024 Aug 13:S0735-1097(24)07958.
     PubMed    
     
     
     
276. PATEL RB
     Mechanistic Insights of SGLT2 Inhibition in Heart Failure Through Proteomics: Appreciating the Cardiovascular-Kidney Connection.
     J Am Coll Cardiol. 2024 Aug 12:S0735-1097(24)08016.
     PubMed    
     
     
     
277. MAHENDIRAN T, Bertolone D, Viscusi MM, Gallinoro E, et al
     The Influence of Epicardial Resistance on Microvascular Resistance Reserve.
     J Am Coll Cardiol. 2024;84:512-521.
     PubMed     Abstract available
     
     
     
278. INZUCCHI SE, Arai AE
     Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes.
     J Am Coll Cardiol. 2024;84:558-560.
     PubMed    
     
     
     July 2024
279. CARNEY RM, Freedland KE, Rich MW
     Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?
     J Am Coll Cardiol. 2024;84:482-489.
     PubMed     Abstract available
     
     
     
280. NANNA MG, Mangalesh S
     Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial Infarction.
     J Am Coll Cardiol. 2024;84:478-481.
     PubMed    
     
     
     
281. SPIRITO A, Sartori S, Koshy AN, Feng Y, et al
     Mortality After Procedural or Spontaneous Myocardial Infarction.
     J Am Coll Cardiol. 2024;84:467-477.
     PubMed     Abstract available
     
     
     
282. PLEIN S, Bulluck H
     Prognostic Significance of Peri-Infarct Ischemia: More Than the Sum of Its Parts.
     J Am Coll Cardiol. 2024;84:430-433.
     PubMed    
     
     
     
283. BERNHARD B, Ge Y, Antiochos P, Heydari B, et al
     Association of Adverse Clinical Outcomes With Peri-Infarct Ischemia Detected by Stress Cardiac Magnetic Imaging.
     J Am Coll Cardiol. 2024;84:417-429.
     PubMed     Abstract available
     
     
     
284. SONG WL, Ramirez VN, Wells QS
     Revealing the Potential of Lipidomics: Improving Cardiovascular Risk Assessment.
     J Am Coll Cardiol. 2024;84:447-449.
     PubMed    
     
     
     
285. WU J, Giles C, Dakic A, Beyene HB, et al
     Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention.
     J Am Coll Cardiol. 2024;84:434-446.
     PubMed     Abstract available
     
     
     
286. EZAD SM, McEntegart M, Dodd M, Didagelos M, et al
     Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy.
     J Am Coll Cardiol. 2024;84:340-350.
     PubMed     Abstract available
     
     
     
287. BANNING AP
     Revascularization Strategies in Patients With MI and MVD: Have We Got the Answers?
     J Am Coll Cardiol. 2024;84:295-297.
     PubMed    
     
     
     
288. REDDY RK, Howard JP, Jamil Y, Madhavan MV, et al
     Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis.
     J Am Coll Cardiol. 2024;84:276-294.
     PubMed     Abstract available
     
     
     
289. BABER U
     Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter?
     J Am Coll Cardiol. 2024;84:273-275.
     PubMed    
     
     
     
290. EBONG IA, Quesada O, Fonkoue IT, Mattina D, et al
     The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2024;84:298-314.
     PubMed     Abstract available
     
     
     
291. CARVALHO MF, Cabral M, Goncalves C, Graca Santos L, et al
     An Intramyocardial Mass Mimicking ST-Segment Elevation Myocardial Infarct at Presentation.
     J Am Coll Cardiol. 2024;84:229-231.
     PubMed     Abstract available
     
     
     
292. SANDNER S, Redfors B, An KR, Harik L, et al
     Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications.
     J Am Coll Cardiol. 2024;84:182-191.
     PubMed     Abstract available
     
     
     
293. ARNOLD N, Blaum C, Gossling A, Brunner FJ, et al
     Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease.
     J Am Coll Cardiol. 2024;84:165-177.
     PubMed     Abstract available
     
     
     
294. LINCOFF AM, Ray KK, Sasiela WJ, Haddad T, et al
     Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.
     J Am Coll Cardiol. 2024;84:152-162.
     PubMed     Abstract available
     
     
     
295. KHERA R, Oikonomou EK, Nadkarni GN, Morley JR, et al
     Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2024;84:97-114.
     PubMed     Abstract available
     
     
     
296. PACKER M
     Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our Fire.
     J Am Coll Cardiol. 2024;84:78-96.
     PubMed     Abstract available
     
     
     
297. WARRAICH HJ, Califf RM
     The FDA and the Cardiovascular Community.
     J Am Coll Cardiol. 2024;84:124-129.
     PubMed    
     
     
     June 2024
298. MORTENSEN MB, Jensen JM, Ronnow Sand NP, Kragholm K, et al
     Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events.
     J Am Coll Cardiol. 2024;83:2643-2654.
     PubMed     Abstract available
     
     
     
299. ALMENDRO-DELIA M, Hernandez-Meneses B, Padilla-Rodriguez G, Blanco-Ponce E, et al
     Timing of P2Y(12) Inhibitor Administration in Patients With STEMI Undergoing Primary PCI.
     J Am Coll Cardiol. 2024;83:2629-2639.
     PubMed     Abstract available
     
     
     
300. WEISFELDT ML, Sisson SD
     Evaluating Long-Term Care After ST-Segment Elevation Myocardial Infarction With a Population-Based Comprehensive Medical Record.
     J Am Coll Cardiol. 2024;83:2626-2628.
     PubMed    
     
     
     
301. THRANE PG, Olesen KKW, Thim T, Gyldenkerne C, et al
     10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population.
     J Am Coll Cardiol. 2024;83:2615-2625.
     PubMed     Abstract available
     
     
     
302. CHAN YH, Zhao JV, Au Yeung SL, Wong YK, et al
     Early Renal Dysfunction in Middle-Aged Adults Predicts Fatal and Nonfatal Cardiovascular Events.
     J Am Coll Cardiol. 2024;83:2711-2713.
     PubMed    
     
     
     
303. VERVOORT D, Wang R, Li G, Filbey L, et al
     Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2024;83:2690-2707.
     PubMed     Abstract available
     
     
     
304. A FRY ET
     Private Equity in Cardiovascular Practice: Solution or Symptom.
     J Am Coll Cardiol. 2024 Jun 21:S0735-1097(24)07610.
     PubMed    
     
     
     
305. MENSAH GA, Myers T, Schmelzer R Jr, Spaeth S, et al
     Turning Data Into Action: The JACC Global Burden of Cardiovascular Diseases and Risks Interactive Tool and Resources.
     J Am Coll Cardiol. 2024;83:2610-2613.
     PubMed    
     
     
     
306. WALSH MN, Lindenfeld J
     Gender Diversity in Cardiovascular Journal Authorship: So Much Time, So Little Progress.
     J Am Coll Cardiol. 2024;83:2469-2471.
     PubMed    
     
     
     
307. GOEL R, Sartori S, Vogel B, Okoli K, et al
     Geographic Mapping of Gender Disparities in Authorship of Cardiovascular Literature.
     J Am Coll Cardiol. 2024;83:2458-2468.
     PubMed     Abstract available
     
     
     
308. AMINIAN A, Wang L, Al Jabri A, Wilson R, et al
     Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care.
     J Am Coll Cardiol. 2024 Jun 13:S0735-1097(24)07559.
     PubMed     Abstract available
     
     
     
309. MIERES JH, Kuvin JT, Roswell RO
     Cardiovascular Health, Juneteenth 2024: Are We Thriving Together or Not?
     J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07555.
     PubMed    
     
     
     
310. ARUN AS, Sawano M, Lu Y, Warner F, et al
     Excess Cardiovascular Mortality Among Black Americans 2000-2022: A JACC Report Card.
     J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07546.
     PubMed    
     
     
     
311. JOHANNESEN CDL, Langsted A, Nordestgaard BG, Mortensen MB, et al
     Excess Apolipoprotein B and Cardiovascular Risk in Women and Men.
     J Am Coll Cardiol. 2024;83:2262-2273.
     PubMed     Abstract available
     
     
     
312. ITCHHAPORIA D
     Transforming Care in ACS Patients: A Potential Digital Revolution in Post-Percutaneous Coronary Intervention Care.
     J Am Coll Cardiol. 2024;83:2260-2261.
     PubMed    
     
     
     
313. KOCHAR A, Gattani R, Vaduganathan M
     Patient Selection Is the Key to EMPACTing Development of Heart Failure After Myocardial Infarction.
     J Am Coll Cardiol. 2024;83:2247-2249.
     PubMed    
     
     
     
314. KHATANA SAM
     Climate Change and Cardiovascular Mortality: Will Fewer Cold Days Balance Out More Hot Days?
     J Am Coll Cardiol. 2024;83:2288-2290.
     PubMed    
     
     
     
315. HUNDESSA S, Huang W, Zhao Q, Wu Y, et al
     Global and Regional Cardiovascular Mortality Attributable to Nonoptimal Temperatures Over Time.
     J Am Coll Cardiol. 2024;83:2276-2287.
     PubMed     Abstract available
     
     
     
316. REDFORS B, Gaudino MFL
     Reply: Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part.
     J Am Coll Cardiol. 2024;83:e219.
     PubMed    
     
     
     
317. FERREIRA RM, Salis LHA, de Souza E Silva NA
     Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part.
     J Am Coll Cardiol. 2024;83:e217.
     PubMed    
     
     
     
318. WELT FGP, Batchelor W, Spears JR, Penna C, et al
     Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement.
     J Am Coll Cardiol. 2024;83:2196-2213.
     PubMed     Abstract available
     
     
     
319. FAYAD ZA, Robson PM, Fuster V
     Rethinking Heart Attack Prevention: The Myth of the "Vulnerable Plaque" and Reality of Patient Risk.
     J Am Coll Cardiol. 2024;83:2145-2147.
     PubMed    
     
     
     
320. WANG KL, Balmforth C, Meah MN, Daghem M, et al
     Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction.
     J Am Coll Cardiol. 2024;83:2135-2144.
     PubMed     Abstract available
     
     
     
321. CHERTOW GM
     Revisiting a "Paradigm" in Cardiovascular and Kidney Disease.
     J Am Coll Cardiol. 2024;83:2160-2162.
     PubMed    
     
     
     May 2024
322. KANG DY, Ahn JM, Park SJ, Park DW, et al
     Reply: Intravascular Imaging for Complex Coronary Intervention.
     J Am Coll Cardiol. 2024;83:e209.
     PubMed    
     
     
     
323. GUNER A, Akturk IF, Cizgici AY, Uzun F, et al
     Intravascular Imaging for Complex Coronary Intervention.
     J Am Coll Cardiol. 2024;83:e207.
     PubMed    
     
     
     
324. DHARMAKUMAR R, Kumar A
     Hemorrhagic Myocardial Infarction: Light After 50 Years in the Tunnel.
     J Am Coll Cardiol. 2024;83:2063-2065.
     PubMed    
     
     
     
325. LECHNER I, Reindl M, Stiermaier T, Tiller C, et al
     Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI.
     J Am Coll Cardiol. 2024;83:2052-2062.
     PubMed     Abstract available
     
     
     
326. MINER SES, Blair JA, McCarthy MC, Nield LE, et al
     The Complex and Incomplete Relationship Between Exercise Stress Testing and Coronary Microvascular Dysfunction.
     J Am Coll Cardiol. 2024;83:e193-e194.
     PubMed    
     
     
     
327. DIMITRIADIS K, Pyrpyris N, Tsioufis K
     Exercise Electrocardiographic Stress Test for Diagnosing Coronary Microvascular Dysfunction: Tale as Old as Time?
     J Am Coll Cardiol. 2024;83:e189.
     PubMed    
     
     
     
328. SINHA A, Rahman H, Perera D
     Reply: Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function.
     J Am Coll Cardiol. 2024;83:e195-e196.
     PubMed    
     
     
     
329. HUNG CL, Yang NI, Chiang CE
     Cardiovascular Risk Stratification by LV Size Among AF Population: Smaller Is Not Always Better.
     J Am Coll Cardiol. 2024;83:1970-1972.
     PubMed    
     
     
     
330. LI M, Ren L, He L, Lai Y, et al
     Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk.
     J Am Coll Cardiol. 2024;83:1957-1969.
     PubMed     Abstract available
     
     
     
331. SHAPIRO MD, German CA
     Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia.
     J Am Coll Cardiol. 2024;83:1953-1956.
     PubMed    
     
     
     
332. LORUSSO R, Matteucci M, Lerakis S, Ronco D, et al
     Postmyocardial Infarction Ventricular Aneurysm: JACC Focus Seminar 5/5.
     J Am Coll Cardiol. 2024;83:1917-1935.
     PubMed     Abstract available
     
     
     
333. LORUSSO R, Cubeddu RJ, Matteucci M, Ronco D, et al
     Ventricular Pseudoaneurysm and Free Wall Rupture After Acute Myocardial Infarction: JACC Focus Seminar 4/5.
     J Am Coll Cardiol. 2024;83:1902-1916.
     PubMed     Abstract available
     
     
     
334. CUBEDDU RJ, Lorusso R, Ronco D, Matteucci M, et al
     Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5.
     J Am Coll Cardiol. 2024;83:1886-1901.
     PubMed     Abstract available
     
     
     
335. APPLE FS
     Early Safe Rule Out Using High-Sensitivity Cardiac Troponin: The Role of Sex.
     J Am Coll Cardiol. 2024;83:1867-1869.
     PubMed    
     
     
     
336. ALEXANDER GC, Moore TJ, Brass EP
     Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
     J Am Coll Cardiol. 2024;83:1883-1885.
     PubMed    
     
     
     
337. HOLT A, Strange JE, Rasmussen PV, Nouhravesh N, et al
     Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
     J Am Coll Cardiol. 2024;83:1870-1882.
     PubMed     Abstract available
     
     
     
338. GUSEH JS 2ND, Januzzi JL Jr
     The Hidden Cardiovascular Crisis Among Former NFL Athletes: After the HUDDLE.
     J Am Coll Cardiol. 2024;83:1838-1840.
     PubMed    
     
     
     
339. SIMADER FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al
     Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
     J Am Coll Cardiol. 2024 May 10:S0735-1097(24)06948.
     PubMed     Abstract available
     
     
     
340. OSTROMINSKI JW, Claggett BL, Miao ZM, Mc Causland FR, et al
     Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis.
     J Am Coll Cardiol. 2024 May 9:S0735-1097(24)07204.
     PubMed    
     
     
     
341. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Simader FA, et al
     N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2024 May 8:S0735-1097(24)06824.
     PubMed     Abstract available
     
     
     
342. ESTEVEZ-LOUREIRO R, Lorusso R, Taramasso M, Torregrossa G, et al
     Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5.
     J Am Coll Cardiol. 2024;83:1799-1817.
     PubMed     Abstract available
     
     
     
343. GOLDSTEIN JA, Lerakis S, Moreno PR
     Right Ventricular Myocardial Infarction-A Tale of Two Ventricles: JACC Focus Seminar 1/5.
     J Am Coll Cardiol. 2024;83:1779-1798.
     PubMed     Abstract available
     
     
     
344. BLANKSTEIN R, Shiyovich A
     Can Plaque Imaging Improve Risk Assessment Among Individuals With Elevated Lp(a)?
     J Am Coll Cardiol. 2024;83:1756-1759.
     PubMed    
     
     
     
345. YU MM, Wang ML, Wang JJ, Lin BL, et al
     Association of Lipoprotein(a) Levels With Myocardial Infarction in Patients With Low-Attenuation Plaque.
     J Am Coll Cardiol. 2024;83:1743-1755.
     PubMed     Abstract available
     
     
     
346. NATARAJAN P, Bellomo TR
     Clonal Hematopoiesis Among Patients With Asymptomatic Carotid Stenosis Compounds Risk of Cardiovascular Death.
     J Am Coll Cardiol. 2024;83:1728-1730.
     PubMed    
     
     
     
347. JAGER R, Hoke M, Mayer FJ, Boden S, et al
     Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
     J Am Coll Cardiol. 2024;83:1717-1727.
     PubMed     Abstract available
     
     
     
348. SANTOS-PARDO I, Andersson Franko M, Lagerqvist B, Ritsinger V, et al
     Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
     J Am Coll Cardiol. 2024 May 7:S0735-1097(24)06933.
     PubMed     Abstract available
     
     
     
349. ALI ZA, Landmesser U, Maehara A, Shin D, et al
     OCT-Guided versus Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy.
     J Am Coll Cardiol. 2024 May 6:S0735-1097(24)07085.
     PubMed     Abstract available
     
     
     
350. EERDEKENS R, El Farissi M, De Maria GL, van Royen N, et al
     Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction.
     J Am Coll Cardiol. 2024 May 3:S0735-1097(24)06759.
     PubMed     Abstract available
     
     
     April 2024
351. PICCOLO R, Angellotti D, Simonetti F, Leone A, et al
     Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention.
     J Am Coll Cardiol. 2024;83:1713-1715.
     PubMed    
     
     
     
352. QUESADA O, Crousillat D, Rodriguez F, Bravo-Jaimes K, et al
     Cardiovascular Disease in Hispanic Women: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2024;83:1702-1712.
     PubMed     Abstract available
     
     
     
353. BOULESTREAU R, Spiewak M, Januszewicz A, Kreutz R, et al
     Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2024;83:1688-1701.
     PubMed     Abstract available
     
     
     
354. HUANG T
     Low Delta Wave Activity During Sleep Promotes Cardiovascular Disease Risk: What's Next?
     J Am Coll Cardiol. 2024;83:1685-1687.
     PubMed    
     
     
     
355. PARSA S, Saleh A, Raygor V, Hoeting N, et al
     Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2024;83:1557-1567.
     PubMed     Abstract available
     
     
     
356. ZERN EK, Gupta T, Ryoo Ali HJ, Thakker P, et al
     A Leadership Program to Support Career Development of Cardiovascular Chief Fellows.
     J Am Coll Cardiol. 2024;83:1623-1625.
     PubMed    
     
     
     
357. ELKIND MSV
     How Physical Activity Lowers Cardiovascular Risk: Exercise Can Change Your Mind.
     J Am Coll Cardiol. 2024;83:1554-1556.
     PubMed    
     
     
     
358. ZUREIGAT H, Osborne MT, Abohashem S, Mezue K, et al
     Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity.
     J Am Coll Cardiol. 2024;83:1543-1553.
     PubMed     Abstract available
     
     
     
359. WONG ND, Fan W, Hu X, Ballantyne C, et al
     Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
     J Am Coll Cardiol. 2024;83:1511-1525.
     PubMed     Abstract available
     
     
     
360. BOROVAC JA
     Unlocking the Gates of ISCHEMIA: Moving Toward Personalized Angina Management for Chronic Coronary Syndrome.
     J Am Coll Cardiol. 2024;83:1367-1369.
     PubMed    
     
     
     
361. ARNOLD SV, Jones PG, Maron DJ, Cohen DJ, et al
     Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.
     J Am Coll Cardiol. 2024;83:1353-1366.
     PubMed     Abstract available
     
     
     
362. KOREN MJ, Rodriguez F, East C, Toth PP, et al
     An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease.
     J Am Coll Cardiol. 2024 Apr 7:S0735-1097(24)06624.
     PubMed     Abstract available
     
     
     
363. SCHNEIDER PA, Olin JW
     Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
     J Am Coll Cardiol. 2024;83:1222-1224.
     PubMed    
     
     
     
364. KONTOS MC, de Lemos JA
     Chest Pain in the Emergency Department: Chasing Perfection.
     J Am Coll Cardiol. 2024;83:1191-1193.
     PubMed    
     
     
     
365. MAHLER SA, Ashburn NP, Supples MW, Hashemian T, et al
     Validation of the ACC Expert Consensus Decision Pathway for Patients With Chest Pain.
     J Am Coll Cardiol. 2024;83:1181-1190.
     PubMed     Abstract available
     
     
     
366. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
     Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
     J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
     PubMed     Abstract available
     
     
     
367. MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al
     Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
     J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940.
     PubMed    
     
     
     March 2024
368. MORENO PR, Fuster V
     JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction.
     J Am Coll Cardiol. 2024 Mar 30:S0735-1097(24)06820.
     PubMed    
     
     
     
369. AI S, Ye S, Li G, Leng Y, et al
     Association of Disrupted Delta Wave Activity During Sleep With Long-Term Cardiovascular Disease and Mortality.
     J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)00484.
     PubMed     Abstract available
     
     
     
370. ALSHAHRANI NS, Hartley A, Howard J, Hajhosseiny R, et al
     Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial.
     J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)06709.
     PubMed     Abstract available
     
     
     
371. ELIAS P, Jain S, Poterucha T, Randazzo M, et al
     Artificial Intelligence for Cardiovascular Care - Part 1: Advances: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06742.
     PubMed     Abstract available
     
     
     
372. JAIN S, Elias P, Poterucha T, Randazzo M, et al
     Artificial Intelligence in Cardiovascular Care - Part 2: Applications: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06744.
     PubMed     Abstract available
     
     
     
373. POVSIC TJ, Korjian S, Bahit MC, Chi G, et al
     Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
     J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06702.
     PubMed     Abstract available
     
     
     
374. BATCHELOR WB, Damluji AA
     Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
     J Am Coll Cardiol. 2024;83:1082-1084.
     PubMed    
     
     
     
375. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
     Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
     J Am Coll Cardiol. 2024;83:1073-1081.
     PubMed     Abstract available
     
     
     
376. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
     Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
     J Am Coll Cardiol. 2024;83:1059-1069.
     PubMed     Abstract available
     
     
     
377. SZAREK M, Bhatt DL, Miller M, Brinton EA, et al
     Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
     J Am Coll Cardiol. 2024 Mar 15:S0735-1097(24)00384.
     PubMed     Abstract available
     
     
     
378. LI Z, Wereski R, Anand A, Lowry MT, et al
     Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule-out Myocardial Infarction at Presentation.
     J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00912.
     PubMed     Abstract available
     
     
     
379. WILSON BH, Wu JC, Fang JC, Hurwitz JL, et al
     Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
     J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00473.
     PubMed    
     
     
     
380. OKOH AK, Amponsah MKD, Cheffet-Walsh S, Patel M, et al
     Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members.
     J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00988.
     PubMed     Abstract available
     
     
     
381. BLAHA MJ, Bhatia HS
     Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy.
     J Am Coll Cardiol. 2024 Mar 9:S0735-1097(24)00944.
     PubMed    
     
     
     
382. HANSEN MK, Olesen KKW, Gyldenkerne C, Thrane PG, et al
     Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.
     J Am Coll Cardiol. 2024;83:956-958.
     PubMed    
     
     
     
383. SCHWANN TA, Engelman DT
     Anemia and Sex Disparity in CABG Mortality: In Search of a Grand Unified Theory.
     J Am Coll Cardiol. 2024;83:929-931.
     PubMed    
     
     
     
384. MANN DL, Nicolas J, Claggett B, Miao ZM, et al
     Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
     J Am Coll Cardiol. 2024;83:904-914.
     PubMed     Abstract available
     
     
     
385. MUKHERJEE D
     Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?
     J Am Coll Cardiol. 2024;83:901-903.
     PubMed    
     
     
     
386. LEE JM, Kim H, Park YS, Jo HH, et al
     Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.
     J Am Coll Cardiol. 2024;83:890-900.
     PubMed     Abstract available
     
     
     
387. HARIK L, Habib RH, Dimagli A, Rahouma M, et al
     Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.
     J Am Coll Cardiol. 2024;83:918-928.
     PubMed     Abstract available
     
     
     
388. BERMAN AN, Biery DW, Besser SA, Singh A, et al
     Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
     J Am Coll Cardiol. 2024;83:873-886.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.